Calgary, AB – TheNewswire - May 19, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is undertaking an offering of up to 66,666,667 share “ Units ” at a price of $0.03 per Unit (the “ Offering ”) for proceeds of up to $2,000,000.  Each Unit will consist [...]

Calgary, AB – May 9, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the departure of two members of its Board of Directors (the “Board”). Dr. Alberto Sola Agullo has decided to resign from the Board in order to focus his time on [...]

Calgary, AB – TheNewswire - April 13, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has processed a closing of $180,000 under its previously announced (see News Release of March 16, 2023) offering of convertible debt securities (the “Offering”).  The Offering consisted of “Secured [...]

Calgary, AB – TheNewswire - March 30, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has reached an agreement (the “ Offer ”) to sell its 20-acre undeveloped island property located in Belize (the “ Property ”) for USD 1,300,000.  A summary of the terms of the sale [...]

Calgary, AB - TheNewswire - March 16, 2023 - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that following preliminary approval by the TSX Venture Exchange (the “TSXV”), it has slightly modified the terms of its pending offering of convertible debt securities (the “ Offering ”, as was described in the Company’s prior [...]

Calgary, AB – TheNewswire - February 6, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering of convertible debt securities (the “ Offering ”).  The Offering consists of up to $5 million of “Secured Guarantee Convertible Notes” (the “ Notes ”) which [...]

Calgary, AB – TheNewswire - January 23, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s addiction and mental health treatment clinic, the Kelburn Recovery Center (“ Kelburn ”), which operates near Winnipeg, Manitoba via a wholly-owned subsidiary of UI, has re-opened effective January 23, 2023. Dr. [...]

Calgary, AB – TheNewswire - January 4, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, is pleased to provide a year end summary of 2022 accomplishments. Nick Karos, Chief Executive Officer and board member of [...]

Calgary, AB – TheNewswire - December 9, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, announces that it has agreed to issue 350,000 common shares (at a deemed price of $0.05) as part of a settlement agreement related to a claim filed in August 2021 by a [...]

Calgary, AB – December 1, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at [...]